Guidelines on Abstracts

The deadline for abstract submissions for inclusion at ISoP 2010 has now passed.


Abstracts must be submitted only in ENGLISH.

Abstracts whose full papers have already been published will not be considered for inclusion.

Abstracts could be from fields such as:

  1. Risk Management Plans
  2. Signal Detection
  3. Periodic Safety Update Reports
  4. Vaccine Pharmacovigilance
  5. Pharmacovigilance Systems for HIV/Malaria/Tuberculosis
  6. Pharmacovigilance in Low-resource Settings
  7. Pharmacovigilance in Public Health Programmes
  8. Cost-effectiveness of Pharmacovigilance Systems
  9. Models for Predicting Drug Safety
  10. Medication Errors Reporting Schemes
  11. Communication in Drug Safety
  12. Other topics (none of the above), like drug utilisation, pharmacoeconomics, statistics and ethical issues

Abstracts will be reviewed by the ISoP 2010 Scientific Committee, and its decision will be notified to authors by the end of July 2010.

Scientific Committee’s decisions will be based upon evaluation of its scientific standard. The Scientific Committee will allocate each accepted abstract to the most appropriate form of presentation.

After selection, all presenting authors will be sent full information regarding PowerPoint preparation, poster size, style and layout, as appropriate. All posters accepted for the Annual Meeting are eligible for the poster prizes which will be awarded for the three best posters at the 10th ISoP Annual Meeting.

Accepted abstracts which have been received by the submission deadline will be published in ISoP’s official journal, Drug Safety.

If an abstract is accepted for presentation (oral or poster), one author or the author's designee must register and attend the conference to present the abstract to have it published in the conference programme.

If you have any questions regarding preparing, submitting, amending or withdrawing an abstract, please contact:

E-mail: /

Phone: +233-21-332675

Fax: +233-21-332975